Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1371/journal.pone.0197400 http://scihub22266oqcxt.onion/10.1371/journal.pone.0197400 29799851!5969743!29799851     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       PLoS+One 2018 ; 13 (5): e0197400 Nephropedia Template TP {{tp|p=29799851|t=2018. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease |pdf=|usr=}}{{29799851}} gab.com Text Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease JO: PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=29799851 #FOAvip BACKGROUND: Proton pump inhibitors (PPIs) are one of the most widely prescribed medications across the world. PPIs have been associated with significant electrolyte abnormalities including hypomagnesaemia. We explored the prevalence of PPI associated hypomagnesaemia (PPIH) in different Chronic Kidney Disease (CKD) stages, in different PPI agents, and the impact of PPIH on survival in CKD. METHODS: This was a subgroup analysis of the Salford Kidney Study, a prospective, observational, longitudinal study of non-dialysis CKD patients. Patients with outpatient magnesium samples obtained between 2002 and 2013 were included in the analysis. The prevalence hypomagnesaemia based on mean values over 12 months as well as 'ever' hypomagnesaemia were investigated. RESULTS: 1,230 patients were included in this analysis, mean age 64.3+/- 32.3 years and mean eGFR 29.2+/-15.8 ml/min/1.73m2. Mean serum magnesium in those on PPI was significantly lower than those not on PPI overall (0.85+/-0.10 mmolL-1 versus 0.79+/-0.12 mmolL-1 respectively, p<0.001). This finding was maintained at all CKD stages. The adjusted odds ratio (OR) for mean hypomagnesaemia in PPI use was 1.12 (95% CI 1.06-1.18) p = <0. 'Ever hypomagnesaemia' had an OR of 1.12 (95% CI 1.07-1.16) p = <0.001. The expected rise in serum magnesium with declining eGFR was not observed in those on a PPI but was seen in those not on PPI. There was no difference in serum magnesium between PPI drugs. Thiazide diuretics were also associated with hypomagnesaemia independent of PPI use. Cox regression analysis demonstrated no reduction in survival in patients with PPI associated hypomagnesaemia. CONCLUSION: No specific PPI drugs show a favourable profile in regards of risk for hypomagnesaemia in CKD. Avoiding concurrent use of PPI and thiazide may be of value in patients with hypomagnesaemia. Twit Text FOAVip Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease ????PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=29799851 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29799851 #FOAvip English Wikipedia <ref>{{Cite pmid|29799851}}</ref> Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease #MMPMID29799851 Hughes J; Y Y Chiu D; Kalra PA; Green D PLoS One 2018[]; 13 (5): e0197400 PMID29799851show ga BACKGROUND: Proton pump inhibitors (PPIs) are one of the most widely prescribed medications across the world. PPIs have been associated with significant electrolyte abnormalities including hypomagnesaemia. We explored the prevalence of PPI associated hypomagnesaemia (PPIH) in different Chronic Kidney Disease (CKD) stages, in different PPI agents, and the impact of PPIH on survival in CKD. METHODS: This was a subgroup analysis of the Salford Kidney Study, a prospective, observational, longitudinal study of non-dialysis CKD patients. Patients with outpatient magnesium samples obtained between 2002 and 2013 were included in the analysis. The prevalence hypomagnesaemia based on mean values over 12 months as well as 'ever' hypomagnesaemia were investigated. RESULTS: 1,230 patients were included in this analysis, mean age 64.3+/- 32.3 years and mean eGFR 29.2+/-15.8 ml/min/1.73m2. Mean serum magnesium in those on PPI was significantly lower than those not on PPI overall (0.85+/-0.10 mmolL-1 versus 0.79+/-0.12 mmolL-1 respectively, p<0.001). This finding was maintained at all CKD stages. The adjusted odds ratio (OR) for mean hypomagnesaemia in PPI use was 1.12 (95% CI 1.06-1.18) p = <0. 'Ever hypomagnesaemia' had an OR of 1.12 (95% CI 1.07-1.16) p = <0.001. The expected rise in serum magnesium with declining eGFR was not observed in those on a PPI but was seen in those not on PPI. There was no difference in serum magnesium between PPI drugs. Thiazide diuretics were also associated with hypomagnesaemia independent of PPI use. Cox regression analysis demonstrated no reduction in survival in patients with PPI associated hypomagnesaemia. CONCLUSION: No specific PPI drugs show a favourable profile in regards of risk for hypomagnesaemia in CKD. Avoiding concurrent use of PPI and thiazide may be of value in patients with hypomagnesaemia. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Diuretics/adverse effects[MESH] |Female[MESH] |Glomerular Filtration Rate[MESH] |Humans[MESH] |Kidney Failure, Chronic/*complications/*drug therapy[MESH] |Longitudinal Studies[MESH] |Magnesium Deficiency/*chemically induced/*complications[MESH] |Magnesium/*blood[MESH] |Male[MESH] |Middle Aged[MESH] |Multivariate Analysis[MESH] |Odds Ratio[MESH] |Prevalence[MESH] |Proportional Hazards Models[MESH] |Prospective Studies[MESH] |Proton Pump Inhibitors/*adverse effects[MESH] |Thiazides/adverse effects/chemistry[MESH]Prevalence and outcomes of proton pump inhibitor associated hypomagnes(epmc).pdf DeepDyve Pubget Overpricing